AU2023418349A1 - Method for generating bispecific proteins - Google Patents

Method for generating bispecific proteins Download PDF

Info

Publication number
AU2023418349A1
AU2023418349A1 AU2023418349A AU2023418349A AU2023418349A1 AU 2023418349 A1 AU2023418349 A1 AU 2023418349A1 AU 2023418349 A AU2023418349 A AU 2023418349A AU 2023418349 A AU2023418349 A AU 2023418349A AU 2023418349 A1 AU2023418349 A1 AU 2023418349A1
Authority
AU
Australia
Prior art keywords
protein
antibody
heterodimeric
domain
igg
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2023418349A
Other languages
English (en)
Inventor
Cornelis Adriaan De Kruif
Franziska MORTENSEN
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merus NV
Original Assignee
Merus NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merus NV filed Critical Merus NV
Publication of AU2023418349A1 publication Critical patent/AU2023418349A1/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Gram-positive bacteria
    • C07K16/1271—Micrococcaceae (F); Staphylococcaceae (F), e.g. Staphylococcus (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2809—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against the T-cell receptor (TcR)-CD3 complex
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2827—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against B7 molecules, e.g. CD80, CD86
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/46—Hybrid immunoglobulins
    • C07K16/468—Immunoglobulins having two or more different antigen binding sites, e.g. multifunctional antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/31—Immunoglobulins specific features characterized by aspects of specificity or valency multispecific
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/52—Constant or Fc region; Isotype
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/52—Constant or Fc region; Isotype
    • C07K2317/524—CH2 domain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/52—Constant or Fc region; Isotype
    • C07K2317/526—CH3 domain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
    • C07K2317/732—Antibody-dependent cellular cytotoxicity [ADCC]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU2023418349A 2022-12-27 2023-12-22 Method for generating bispecific proteins Pending AU2023418349A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
NL2033843 2022-12-27
NL2033843 2022-12-27
PCT/NL2023/050681 WO2024144396A1 (en) 2022-12-27 2023-12-22 Method for generating bispecific proteins

Publications (1)

Publication Number Publication Date
AU2023418349A1 true AU2023418349A1 (en) 2025-07-03

Family

ID=85158672

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2023418349A Pending AU2023418349A1 (en) 2022-12-27 2023-12-22 Method for generating bispecific proteins

Country Status (9)

Country Link
US (1) US20260209390A1 (cg-RX-API-DMAC7.html)
EP (1) EP4642811A1 (cg-RX-API-DMAC7.html)
JP (1) JP2026500710A (cg-RX-API-DMAC7.html)
KR (1) KR20250129720A (cg-RX-API-DMAC7.html)
CN (2) CN121824747A (cg-RX-API-DMAC7.html)
AU (1) AU2023418349A1 (cg-RX-API-DMAC7.html)
IL (1) IL321671A (cg-RX-API-DMAC7.html)
TW (1) TW202432587A (cg-RX-API-DMAC7.html)
WO (1) WO2024144396A1 (cg-RX-API-DMAC7.html)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4801687A (en) 1986-10-27 1989-01-31 Bioprobe International, Inc. Monoclonal antibody purification process using protein A
US5151504A (en) 1989-11-17 1992-09-29 E. R. Squibb & Sons, Inc. Method for purification of monoclonal antibodies
PT2560993T (pt) 2010-04-20 2024-09-16 Genmab As Proteínas contendo anticorpo heterodimérico fc e métodos para a produção das mesmas
IN2014CN03887A (cg-RX-API-DMAC7.html) * 2011-10-27 2015-10-16 Genmab As
CA3094318A1 (en) 2018-03-30 2019-10-03 Merus N.V. Multivalent antibody
EP3966238A2 (en) 2019-05-09 2022-03-16 Merus N.V. Variant domains for multimerizing proteins and separation thereof
CN116462766A (zh) 2020-05-21 2023-07-21 美勒斯公司 用于生产ig样分子的方法和手段

Also Published As

Publication number Publication date
KR20250129720A (ko) 2025-08-29
JP2026500710A (ja) 2026-01-08
WO2024144396A1 (en) 2024-07-04
TW202432587A (zh) 2024-08-16
US20260209390A1 (en) 2026-07-23
IL321671A (en) 2025-08-01
EP4642811A1 (en) 2025-11-05
CN121824747A (zh) 2026-04-10
CN120641444A (zh) 2025-09-12

Similar Documents

Publication Publication Date Title
JP7600172B2 (ja) エンジニアリングされたＦｃ構築物に関連する組成物および方法
Strop et al. Generating bispecific human IgG1 and IgG2 antibodies from any antibody pair
JP5681482B2 (ja) 二重特異性抗体およびその作製方法
TWI803876B (zh) 具有交叉結合區定向之雙重可變區類抗體結合蛋白
JP6904902B2 (ja) ドメイン交換抗体
JP2019528051A (ja) 修飾抗原結合Ｆａｂ断片及びこれを含む抗原結合分子
JP7123063B2 (ja) 抗体ドメインの好ましい対形成
CN106397598B (zh) 多价多特异性抗体及免疫杂合蛋白的表达和制备方法
TWI918721B (zh) Egfr結合複合物及其製備和使用方法
KR20220017909A (ko) 단백질 다량체화를 위한 변이체 도메인 및 그의 분리
WO2022166728A1 (zh) 双特异性抗体
Huang et al. A novel efficient bispecific antibody format, combining a conventional antigen-binding fragment with a single domain antibody, avoids potential heavy-light chain mis-pairing
CA3232365A1 (en) Antigen binding polypeptides, antigen binding polypeptide complexes and methods of use thereof in hiv
CN112789058A (zh) 双特异性抗体构建体的下游加工
WO2021193553A1 (ja) 多量体ＩｇＡ抗体の作製法及び多重特異性多量体ＩｇＡ抗体
JP7372638B2 (ja) 抗ｂ型肝炎ウイルス抗体及びその使用
WO2024144396A1 (en) Method for generating bispecific proteins
TW202506725A (zh) 三特異性工程化抗體
AU2021405066A1 (en) Antibody variable domains and antibodies having decreased immunogenicity
WO2025137454A1 (en) Stabilizing homodimer mutations for two cell heterodimer production
Rivera-Castro et al. Comparative analysis of manufacturability and binding of various bispecific antibody architectures
WO2025075529A1 (en) Antibody binds to trbv5-1 segment of human tor domain
WO2023011650A1 (zh) 一种多特异性抗体及其用途
BR122023012219B1 (pt) Polipeptídeo recombinante
BR122024024316B1 (pt) Métodos para produzir uma seringa pré-cheia, para preparação de uma seringa pré-cheia compreendendo aflibercepte e para preparação de uma seringa auto- injetora pré-cheia compreendendo aflibercepte